Apremilast in the therapy of moderate to severe chronic plaque psorias DDDT Dove Medical Press Alterations of gut microbiota for the onset and treatment of psoriasis: A systematic review ScienceDirect Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non lesional and lesional skin Annals of the Rheumatic Diseases Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially